Gromoslaw A. Smolen
Celsius Therapeutics (United States)(US)
Publications by Year
Research Areas
Chromatin Remodeling and Cancer, Hippo pathway signaling and YAP/TAZ, Cancer-related Molecular Pathways, Protein Degradation and Inhibitors, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon(2006)882 cited
- → Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer(2013)844 cited
- → Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752(2006)482 cited
- → Functional genomic landscape of cancer-intrinsic evasion of killing by T cells(2020)461 cited
- → YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway(2009)424 cited
- → The Arabidopsis ATR1 Myb Transcription Factor Controls Indolic Glucosinolate Homeostasis(2004)302 cited
- → Negative Regulation of YAP by LATS1 Underscores Evolutionary Conservation of the Drosophila Hippo Pathway(2008)241 cited
- → Suppressors of Superoxide Dismutase (SOD1) Deficiency in Saccharomyces cerevisiae(1998)182 cited
- → Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase(2019)148 cited
- → Rational design of a ligand-controlled protein conformational switch(2013)128 cited